The company sat on Thursday.

The nursing home trial involved both residents and staff who were treated with either a placebo or the anti body drug called Bam Lin of a mob.

After an eight week period, the residents were 80% less likely to develop symptomatic of in 19 if they were treated with the drug Bam Lenovo.

MAB was given emergency use authorization by the FDA last October for non hospitalized co vid patients, although the need for such antibody drugs has dwindled as vaccines become more widely available.

Eli Lilly's chief scientific officer said he doesn't see Ban Lin of a map as an alternative to vaccines.

But he said the drug is beneficial if there is an outbreak in a facility where the most vulnerable population resides.